Browse by Journal Title

2022

COVID-19: new disease mechanism is simultaneously a therapeutic target.
Schmitt, C.A.
memo: Magazine of European Medical Oncology 15 (2): 100-101. June 2022

2020

ASH highlights 2019: "aggressive B-cell lymphoma".
Schmitt, C.A.
memo: Magazine of European Medical Oncology 13 (3): 266-269. 20 May 2020

Ensuring center quality, proper patient selection and fair access to chimeric antigen receptor T-cell therapy: position statement of the Austrian CAR-T Cell Network.
Greinix, H.T. and Attarbaschi, A. and Girschikofsky, M. and Greil, R. and Holter, W. and Neumeister, P. and Peters, C. and Petzer, A. and Rudzki, J. and Schlenke, P. and Schmitt, C.A. and Schwinger, W. and Wolf, D. and Worel, N. and Jaeger, U.
memo: Magazine of European Medical Oncology 13 (1): 27-31. March 2020

2019

Editorial: critical issues in lymphoma management.
Fuchs, D. and Schmitt, C.A.
memo: Magazine of European Medical Oncology 12 (1): 1. March 2019